Deborah A. Kuban

20.6k total citations · 6 hit papers
272 papers, 14.9k citations indexed

About

Deborah A. Kuban is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Deborah A. Kuban has authored 272 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Pulmonary and Respiratory Medicine, 130 papers in Radiation and 47 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Deborah A. Kuban's work include Prostate Cancer Diagnosis and Treatment (199 papers), Prostate Cancer Treatment and Research (164 papers) and Advanced Radiotherapy Techniques (130 papers). Deborah A. Kuban is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (199 papers), Prostate Cancer Treatment and Research (164 papers) and Advanced Radiotherapy Techniques (130 papers). Deborah A. Kuban collaborates with scholars based in United States, Canada and Spain. Deborah A. Kuban's co-authors include Lei Dong, Alan Pollack, Andrew K. Lee, Eugene Huang, George Starkschall, Susan L. Tucker, Paul F. Schellhammer, Rex Cheung, Radhe Mohan and Howard M. Sandler and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Deborah A. Kuban

268 papers receiving 14.5k citations

Hit Papers

Quality of Life and Satis... 2002 2026 2010 2018 2008 2002 2007 2007 2005 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Deborah A. Kuban 11.9k 7.3k 3.4k 2.0k 1.5k 272 14.9k
Jeff M. Michalski 11.8k 1.0× 7.4k 1.0× 4.8k 1.4× 2.2k 1.1× 1.9k 1.3× 373 15.7k
Mack Roach 12.7k 1.1× 7.1k 1.0× 3.8k 1.1× 2.3k 1.1× 1.7k 1.2× 374 16.2k
Steven A. Leibel 11.1k 0.9× 8.5k 1.2× 6.0k 1.7× 2.8k 1.4× 1.7k 1.1× 208 17.1k
Patrick A. Kupelian 10.1k 0.9× 7.9k 1.1× 4.6k 1.3× 1.6k 0.8× 1.1k 0.8× 342 13.8k
Gerald E. Hanks 13.9k 1.2× 6.6k 0.9× 3.3k 1.0× 3.9k 1.9× 2.2k 1.5× 393 19.4k
Juanita Crook 5.6k 0.5× 3.1k 0.4× 1.5k 0.4× 1.9k 0.9× 1.0k 0.7× 278 8.3k
Margie Hunt 8.1k 0.7× 8.2k 1.1× 4.4k 1.3× 1.9k 0.9× 815 0.5× 207 11.9k
Eric M. Horwitz 7.6k 0.6× 3.7k 0.5× 1.5k 0.4× 1.7k 0.8× 1.3k 0.9× 292 10.3k
Anthony V. D’Amico 13.2k 1.1× 2.4k 0.3× 1.8k 0.5× 2.6k 1.3× 2.4k 1.6× 361 16.4k
Mitchell S. Anscher 6.6k 0.6× 3.4k 0.5× 5.0k 1.4× 2.5k 1.2× 2.4k 1.6× 268 12.8k

Countries citing papers authored by Deborah A. Kuban

Since Specialization
Citations

This map shows the geographic impact of Deborah A. Kuban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Kuban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Kuban more than expected).

Fields of papers citing papers by Deborah A. Kuban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Kuban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Kuban. The network helps show where Deborah A. Kuban may publish in the future.

Co-authorship network of co-authors of Deborah A. Kuban

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Kuban. A scholar is included among the top collaborators of Deborah A. Kuban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Kuban. Deborah A. Kuban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hassanzadeh, Comron, Osama Mohamad, Teresa L. Bruno, et al.. (2025). Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy. 24(2). 231–237. 1 indexed citations
3.
Hassanzadeh, Comron, Deborah A. Kuban, Roland L. Bassett, et al.. (2024). Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S56–S56. 1 indexed citations
4.
Johnston, Patricia A., et al.. (2020). COVID-19 and Oncology: Operationalizing Best Practices Across Collaborative Health Systems. Clinical journal of oncology nursing. 24(4). 444–447. 3 indexed citations
5.
Hoffman, Richard M., Robert J. Volk, Brian F. Chapin, et al.. (2019). Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options. International Journal of Radiation Oncology*Biology*Physics. 105(1). E442–E442. 1 indexed citations
6.
Hoffman, Karen E., Khinh Ranh Voong, Lawrence B. Levy, et al.. (2018). Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. Journal of Clinical Oncology. 36(29). 2943–2949. 91 indexed citations
7.
Le, Yen‐Chi L., Stephanie L. McFall, Theresa Byrd, et al.. (2016). Is “Active Surveillance” an Acceptable Alternative?: A Qualitative Study of Couples’ Decision Making about Early-Stage, Localized Prostate Cancer. Narrative Inquiry in Bioethics. 6(1). 51–61. 14 indexed citations
8.
Hoffman, Karen E., Lawrence B. Levy, Andrew K. Lee, et al.. (2012). Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?. International Journal of Radiation Oncology*Biology*Physics. 85(3). 693–699. 41 indexed citations
9.
Choi, Seungtaek, Teresa L. Bruno, Andrew K. Lee, et al.. (2011). Long-term tumor control after brachytherapy for base-of-prostate cancer. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Archambault, Louis, Tina M. Briere, Falk Pönisch, et al.. (2010). Toward a Real-Time In Vivo Dosimetry System Using Plastic Scintillation Detectors. International Journal of Radiation Oncology*Biology*Physics. 78(1). 280–287. 79 indexed citations
11.
Tucker, S.L., Lei Dong, Walter Bosch, et al.. (2007). Fit of a Generalized Lyman Normal-Tissue Complication Probability (NTCP) Model to Grade ≥ 2 Late Rectal Toxicity Data From Patients Treated on Protocol RTOG 94-06. International Journal of Radiation Oncology*Biology*Physics. 69(3). S8–S9. 27 indexed citations
12.
Crevoisier, R. de, A Melancon, Deborah A. Kuban, et al.. (2007). Changes in the Pelvic Anatomy After an IMRT Treatment Fraction of Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1529–1536. 37 indexed citations
13.
Cheung, R., et al.. (2004). The dose response characteristics of low and intermediate risk prostate cancer treated with external beam radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 60. S451–S452. 1 indexed citations
14.
Cheung, Rex, Susan L. Tucker, Lei Dong, et al.. (2004). Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 58(5). 1513–1519. 52 indexed citations
15.
Rosser, Charles J., Motoyoshi Tanaka, Louis L. Pisters, et al.. (2004). Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Therapy. 11(4). 273–279. 52 indexed citations
16.
Hung, Arthur, Larry Levy, & Deborah A. Kuban. (2002). Stage T1c Prostate Cancer. The Cancer Journal. 8(6). 440–444. 7 indexed citations
17.
Campbell, Timothy, John C. Blasko, E. David Crawford, et al.. (2001). Clinical staging of prostate cancer: Reproducibility and clarification of issues. International Journal of Cancer. 96(3). 198–209. 19 indexed citations
18.
Kuban, Deborah A., Anas M. El‐Mahdi, & Paul F. Schellhammer. (1995). Potential benefit of improved local tumor control in patients with prostate carcinoma. Cancer. 75(9). 2373–2382. 34 indexed citations
19.
Kuban, Deborah A., Anas M. El‐Mahdi, & Paul F. Schellhammer. (1989). Mortality in prostatic carcinoma. Urology. 33(1). 1–5. 8 indexed citations
20.
Kuban, Deborah A., Anas M. El‐Mahdi, & Paul F. Schellhammer. (1989). Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma. Cancer. 63(12). 2421–2425. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026